363 related articles for article (PubMed ID: 32185886)
1. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
2. Bayesian selective response-adaptive design using the historical control.
Kim MO; Harun N; Liu C; Khoury JC; Broderick JP
Stat Med; 2018 Nov; 37(26):3709-3722. PubMed ID: 29900577
[TBL] [Abstract][Full Text] [Related]
3. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
4. Bayesian adaptive design for covariate-adaptive historical control information borrowing.
Jin H; Kim MO; Scheffler A; Jiang F
Stat Med; 2023 Dec; 42(29):5338-5352. PubMed ID: 37750361
[TBL] [Abstract][Full Text] [Related]
5. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
Kaplan D; Chen J; Yavuz S; Lyu W
Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
[TBL] [Abstract][Full Text] [Related]
6. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
Warren JL; Wang Q; Ciarleglio MM
Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
Su L; Chen X; Zhang J; Yan F
JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
[TBL] [Abstract][Full Text] [Related]
8. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
9. Bayesian borrowing from historical control data in a vaccine efficacy trial.
Peng L; Jin J; Chambonneau L; Zhao X; Zhang J
Pharm Stat; 2023; 22(5):815-835. PubMed ID: 37226586
[TBL] [Abstract][Full Text] [Related]
10. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
Wang X; Suttner L; Jemielita T; Li X
J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
[TBL] [Abstract][Full Text] [Related]
11. A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.
Bennett M; White S; Best N; Mander A
Pharm Stat; 2021 May; 20(3):462-484. PubMed ID: 33474798
[TBL] [Abstract][Full Text] [Related]
12. Use of historical control data for assessing treatment effects in clinical trials.
Viele K; Berry S; Neuenschwander B; Amzal B; Chen F; Enas N; Hobbs B; Ibrahim JG; Kinnersley N; Lindborg S; Micallef S; Roychoudhury S; Thompson L
Pharm Stat; 2014; 13(1):41-54. PubMed ID: 23913901
[TBL] [Abstract][Full Text] [Related]
13. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
[TBL] [Abstract][Full Text] [Related]
14. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
[TBL] [Abstract][Full Text] [Related]
15. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
16. Adaptive designs in critical care trials: a simulation study.
Li W; Cornelius V; Finfer S; Venkatesh B; Billot L
BMC Med Res Methodol; 2023 Oct; 23(1):236. PubMed ID: 37853343
[TBL] [Abstract][Full Text] [Related]
17. Utilization of Adult Data in Designing Pediatric Pharmacokinetic Studies: How Much Are Historical Adult Data Worth?
Hsu CH; Steven Xu X; Wang J; Zhang L; Liu C; Wang Y
J Clin Pharmacol; 2019 Jul; 59(7):989-996. PubMed ID: 30748023
[TBL] [Abstract][Full Text] [Related]
18. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
Fu C; Pang H; Zhou S; Zhu J
Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
[TBL] [Abstract][Full Text] [Related]
19. Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.
Berry SM; Broglio KR; Groshen S; Berry DA
Clin Trials; 2013 Oct; 10(5):720-34. PubMed ID: 23983156
[TBL] [Abstract][Full Text] [Related]
20. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
